Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STATIC IV salbutamol loading dose trial in PICU severe acute asthma
NL-OMON43695Phase 4Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in asthma and status asthmaticus comparing IV salbutamol loading dose + standard care with Placebo loading dose + standard care (2 arms). Primary endpoint: Primary: change in Qureshi asthma score at 1 hour. Started Apr 2017; status: active, not recruiting.
02
Drugs
salbutamol
03
Conditions
asthmastatus asthmaticus
Beyond the preview
Go deeper on NL-OMON43695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43695.